US Stock MarketDetailed Quotes
UPB UpStream Bio
- 25.460
- -0.480-1.85%
Close Nov 15 16:00 ET
- 25.000
- -0.460-1.81%
Post 16:11 ET
1.36BMarket Cap-19614P/E (TTM)
26.115High25.240Low218.36KVolume25.990Open25.940Pre Close5.64MTurnover1.75%Turnover RatioLossP/E (Static)53.60MShares29.46052wk High-8.51P/B318.25MFloat Cap20.74052wk Low--Dividend TTM12.50MShs Float29.460Historical High--Div YieldTTM3.37%Amplitude20.740Historical Low25.838Avg Price1Lot Size
UpStream Bio News
TD Cowen Maintains UpStream Bio(UPB.US) With Buy Rating
TD Cowen Initiates UpStream Bio(UPB.US) With Buy Rating
A Quick Look at Today's Ratings for UpStream Bio(UPB.US), With a Forecast Between $38 to $75
Upstream Bio Initiated at Overweight by Piper Sandler
Upstream Bio Analyst Ratings
Positive Buy Rating for Upstream Bio Driven by Verekitug's Potential in Severe Asthma and Expansion Into CRSwNP and COPD Markets
Promising Market Impact: Yasmeen Rahimi's Buy Rating on Upstream Bio's Verekitug for Asthma and COPD
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
